VetCell Therapeutics

VetCell Therapeutics was a U.S. veterinary regenerative medicine company focused on developing and commercializing cell-based therapies for companion animals. The company operated as a pet-focused subsidiary/division of PrimeGen and pursued autologous and allogeneic stem-cell products for inflammatory and degenerative diseases in dogs and cats. Publicly described programs included ReGen OA for canine osteoarthritis, EvoluGen OA as a platelet-rich plasma therapy for canine osteoarthritis, and DentaHeal, an investigational allogeneic adipose-derived mesenchymal stem cell therapy for feline chronic gingivostomatitis. VetCell also described services such as cell banking and cell expansion for retreatment. Third-party company databases now indicate the business is closed, and its legacy websites appear inactive or repurposed.